Relevance of oxidative stress biomarkers, hemoglobin A1c, troponin-I, and angiotensin-converting enzyme metabolism to blood pressure in acute myocardial infarction: a case-control study

References

• Messner B, Bernhard D. Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Arterioscler Thromb Vasc Biol. 2014;34(3):509–515. doi:10.1161/ATVBAHA.113.300156.
   PubMed Web of Science ®Google Scholar
• Katakami N. Mechanism of development of atherosclerosis and cardiovascular disease in diabetes mellitus. J Atheroscler Thromb. 2018;25(1):27–39. doi:10.5551/jat.RV17014.
   PubMed Web of Science ®Google Scholar
• Anne-Lise Chang P, So-Armah C-CH, A K, et al. Human immunodeficiency virus infection, cardiovascular risk factor profile and risk for acute myocardial infarction. J Acquir Immune Defic Syndr. 1999;22(2):209), doi:10.1097/00126334-199910010-00017.
   PubMedGoogle Scholar
• Ketema EB, Kibret KT. Correlation of fasting and postprandial plasma glucose with HbA1c in assessing glycemic control; systematic review and meta-analysis. Arch Public Health. 2015;73(1):1–9.
   PubMedGoogle Scholar
• Šimić S, Svaguša T, Prkačin I, et al. Relationship between hemoglobin A1c and serum troponin in patients with diabetes and cardiovascular events. J Diab Metab Disord. 2019;18(2):693–704. doi:10.1007/s40200-019-00460-9.
   PubMed Web of Science ®Google Scholar
• Khaw K-T, Wareham N. Glycated hemoglobin as a marker of cardiovascular risk. Curr Opin Lipidol. 2006;17(6):637–643. doi:10.1097/MOL.0b013e3280106b95.
   PubMed Web of Science ®Google Scholar
• Levy D, Larson M, Vasan R, et al. The progression from hypertension to congestive heart failure. ACC Curr J Rev. 1997;2(6):37.
   Google Scholar
• Stevens MJ, Raffel DM, Allman KC, et al. Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk. Circulation. 1998;98(10):961–968. doi:10.1161/01.CIR.98.10.961.
   PubMed Web of Science ®Google Scholar
• Weber T, Auer J, O’Rourke MF, et al. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation. 2004;109(2):184–189. doi:10.1161/01.CIR.0000105767.94169.E3.
   PubMed Web of Science ®Google Scholar
• Böhm M, Schumacher H, Teo KK, et al. Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120–140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. Eur Heart J. 2018;39(33):3105–3114. doi:10.1093/eurheartj/ehy287.
   PubMed Web of Science ®Google Scholar
• Borghi C, Omboni S, Novo S, et al. Efficacy and safety of zofenopril versus ramipril in the treatment of myocardial infarction and heart failure: a review of the published and unpublished data of the randomized double-blind SMILE-4 study. Adv Ther. 2018;35(5):604–618. doi:10.1007/s12325-018-0697-x.
   PubMed Web of Science ®Google Scholar
• Valko M, Leibfritz D, Moncol J, et al. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39(1):44–84. doi:10.1016/j.biocel.2006.07.001.
   PubMed Web of Science ®Google Scholar
• Ding Z, Wang X, Khaidakov M, et al. MicroRNA hsa-let-7 g targets lectin-like oxidized low-density lipoprotein receptor-1 expression and inhibits apoptosis in human smooth muscle cells. Exp Biol Med. 2012;237(9):1093–1100. doi:10.1258/ebm.2012.012082.
   Web of Science ®Google Scholar
• Pham-Huy LA, He H, Pham-Huy C. Free radicals, antioxidants in disease and health. Intern J Biomed Sci IJBS. 2008;4(2):89.
   PubMedGoogle Scholar
• Wilson Tang W, Francis GS, Morrow DA, et al. National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: clinical utilization of cardiac biomarker testing in heart failure. Circulation. 2007;116(5):e99–e109.
   PubMed Web of Science ®Google Scholar
• Smaoui M, Hammami S, Chaaba R, et al. Lipids and lipoprotein(a) concentrations in Tunisian type 2 diabetic patients. J Diab Complicat. 2004;18(5):258–263. doi:10.1016/S1056-8727(03)00075-8.
   PubMed Web of Science ®Google Scholar
• Mehri S, Mahjoub S, Finsterer J, et al. The CC genotype of the angiotensin II type I receptor gene independently associates with acute myocardial infarction in a Tunisian population. J Renin-Angiotensin-Aldosterone Syst. 2011;12(4):595–600. doi:10.1177/1470320310391833.
   PubMed Web of Science ®Google Scholar
• Mehri S, Baudin B, Mahjoub S, et al. Angiotensin-converting enzyme insertion/deletion gene polymorphism in a Tunisian healthy and acute myocardial infarction population. Genet Test Mol Biomark. 2010;14(1):85–91. doi:10.1089/gtmb.2009.0105.
   PubMed Web of Science ®Google Scholar
• Yoshioka T, Kawada K, Shimada T, et al. Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood. Amer J Obstetr Gynecol. 1979;135(3):372–376. doi:10.1016/0002-9378(79)90708-7.
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Striegl G, Puhl H, et al. Continuous monitoring of in vztro oxidation of human low density lipoprotein. Free Radic Res Commun. 1989;6(1):67–75. doi:10.3109/10715768909073429.
   PubMed Web of Science ®Google Scholar
• Flohé L, Günzler WA. Assays of glutathione peroxidase. Methods in Enzymology. Vol. 105. Elsevier; 1984. p. 114–120. doi:10.1016/S0076-6879(84)05015-1.
   Google Scholar
• Collaboration ERF. Diabetes mellitus, fasting glucose, and risk of cause-specific death. New Engl J Med. 2011;364(9):829–841. doi:10.1056/NEJMoa1008862.
   PubMed Web of Science ®Google Scholar
• Robinson LE, Holt TA, Rees K, et al. Effects of exenatide and liraglutide on heart rate, blood pressure and body weight: systematic review and meta-analysis. BMJ Open. 2013;3(1):e001986.
   PubMed Web of Science ®Google Scholar
• Rumley A, Woodward M, Rumley A, et al. Plasma lipid peroxides: relationships to cardiovascular risk factors and prevalent cardiovascular disease. Qjm. 2004;97(12):809–816. doi:10.1093/qjmed/hch130.
   PubMed Web of Science ®Google Scholar
• Polidori MC, Savino K, Alunni G, et al. Plasma lipophilic antioxidants and malondialdehyde in congestive heart failure patients: relationship to disease severity. Free Radical Biology and Medicine. 2002;32(2):148–152.
   Google Scholar
• Anacker C, Luna VM, Stevens GS, et al. Hippocampal neurogenesis confers stress resilience by inhibiting the ventral dentate gyrus. Nature. 2018;559(7712):98–102. doi:10.1038/s41586-018-0262-4.
   PubMed Web of Science ®Google Scholar
• Ito F, Sono Y, Ito T. Measurement and clinical significance of lipid peroxidation as a biomarker of oxidative stress: oxidative stress in diabetes, atherosclerosis, and chronic inflammation. Antioxidants. 2019;8(3):72), doi:10.3390/antiox8030072.
   Web of Science ®Google Scholar
• Tomino Y, Hagiwara S, Gohda T. AGE–RAGE interaction and oxidative stress in obesity-related renal dysfunction. Kidney Int. 2011;80(2):133–135. doi:10.1038/ki.2011.86.
   PubMed Web of Science ®Google Scholar
• Basta G, Lazzerini G, Del Turco S, et al. At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products. Arterioscler Thromb Vasc Biol. 2005;25(7):1401–1407. doi:10.1161/01.ATV.0000167522.48370.5e.
   PubMed Web of Science ®Google Scholar
• Chan SH, Chan JY. Brain stem NOS and ROS in neural mechanisms of hypertension. Antioxid Redox Signal. 2014;20(1):146–163. doi:10.1089/ars.2013.5230.
   PubMed Web of Science ®Google Scholar
• Baradaran A, Nasri H, Rafieian-Kopaei M. Oxidative stress and hypertension: Possibility of hypertension therapy with antioxidants. J Res Med Sci Off J Isfahan Univ Med Sci. 2014;19(4):358.
   Google Scholar
• Montezano AC, Touyz RM. Oxidative stress, Noxs, and hypertension: experimental evidence and clinical controversies. Ann Med. 2012;44(sup1):S2–S16. doi:10.3109/07853890.2011.653393.
   PubMed Web of Science ®Google Scholar
• Arellano-Mendoza MG, Vargas-Robles H, Del Valle-Mondragon L, et al. Prevention of renal injury and endothelial dysfunction by chronic L-arginine and antioxidant treatment. Ren Fail. 2011;33(1):47–53. doi:10.3109/0886022X.2010.541583.
   PubMed Web of Science ®Google Scholar
• Agarwal R. Proinflammatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockade. Amer J Physiol Renal Physiol. 2003;284(4):F863–F869. doi:10.1152/ajprenal.00385.2002.
   PubMed Web of Science ®Google Scholar
• Thannickal VJ, Fanburg BL. Reactive oxygen species in cell signaling. Amer J Physiol Lung Cell Mol Physiol. 2000;279(6):L1005–L1028. doi:10.1152/ajplung.2000.279.6.L1005.
   PubMed Web of Science ®Google Scholar
• Hanna IR, Taniyama Y, Szöcs K, et al. Nad(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antiox Redox Signal. 2002;4(6):899–914. doi:10.1089/152308602762197443.
   PubMed Web of Science ®Google Scholar
• Vassallo DV, Simões MR, Giuberti K, et al. Effects of chronic exposure to mercury on angiotensin-converting enzyme activity and oxidative stress in normotensive and hypertensive rats. Arq Bras Cardiol. 2019;112(4):374–380.
   PubMed Web of Science ®Google Scholar
• Sabatino L, Ndreu R, Vassalle C. Oxidative stress and heart disease: the thyroid hormone mediation. Vessel Plus. 2021;5:3. doi:10.20517/2574-1209.2020.62.
   Google Scholar
• Frangogiannis NG. Regulation of the inflammatory response in cardiac repair. Circ Res. 2012;110(1):159–173. doi:10.1161/CIRCRESAHA.111.243162.
   PubMed Web of Science ®Google Scholar